Pharmaceuticals Search Engine [selected websites]

Wednesday, October 17, 2007

AstraZeneca, Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms

October 16, 2007 - The link between gastroesophageal reflux disease (GERD) and obesity has long been established, but healthcare professionals have had little guidance as to whether obese patients with GERD* should be treated differently than normal-weight patients with GERD. Two studies about obesity and its relationship to GERD were presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting this week... AstraZeneca's Press Release-